Comparison

Sapanisertib European Partner

Item no. TMO-T1838-500mg
Manufacturer TargetMol
CASRN 1224844-38-5
Amount 500 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 500 mg 50 mg 5 mg
Category
Type Inhibitors
Specific against other
Smiles CC(C)n1nc(-c2ccc3oc(N)nc3c2)c2c(N)ncnc12
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias TAK-228,MLN0128,INK 128
Shipping Condition Cool pack
Available
Manufacturer - Targets
PI3K|||mTOR|||Autophagy
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
309.33
Description
Sapanisertib (INK 128) is an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.
Pathways
PI3K/Akt/mTOR signaling|||Autophagy

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close